Bill
Bill > SSB1138
IA SSB1138
IA SSB1138A bill for an act relating to a review of anti-obesity medications by the department of health and human services and the department of administrative services for purposes of the medical assistance program and health insurance plans for public employees.(See SF 552.)
summary
Introduced
02/18/2025
02/18/2025
In Committee
02/18/2025
02/18/2025
Crossed Over
Passed
Dead
Introduced Session
91st General Assembly
Bill Summary
This bill relates to the department of health and human services (HHS) and the department of administrative services (DAS) review of anti-obesity medication for purposes of the medical assistance program and health insurance plans established pursuant to Code chapter 509A for public employees. The bill requires HHS and DAS to review anti-obesity medications, including GLP-1 agonists, for effectiveness, comorbidities, cost savings, and eligibility requirements as described in the bill. HHS and DAS shall submit a report to the general assembly by January 5, 2026, containing HHS’s and DAS’s findings and proposed eligibility requirements.
Committee Categories
Health and Social Services
Sponsors (0)
No sponsors listed
Other Sponsors (1)
Health And Human Services (S)
Last Action
Committee report approving bill, renumbered as SF 552. (on 03/05/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.legis.iowa.gov/legislation/BillBook?ga=91&ba=SSB1138 |
| BillText | https://www.legis.iowa.gov/docs/publications/LGI/91/attachments/SSB1138.html |
Loading...